Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population‐Ascertained Hyperlipidemias

Author:

Rämö Joel T.1,Ripatti Pietari1,Tabassum Rubina1,Söderlund Sanni23,Matikainen Niina23,Gerl Mathias J.4,Klose Christian4,Surma Michal A.45,Stitziel Nathan O.678,Havulinna Aki S.19,Pirinen Matti11011,Salomaa Veikko9,Freimer Nelson B.12,Jauhiainen Matti913,Palotie Aarno11415,Taskinen Marja‐Riitta2,Simons Kai416,Ripatti Samuli11411

Affiliation:

1. Institute for Molecular Medicine Finland HiLIFE University of Helsinki Finland

2. Research Programs Unit Clinical and Molecular Metabolism University of Helsinki Finland

3. Endocrinology Abdominal Center Helsinki University Hospital Helsinki Finland

4. Lipotype GmbH Dresden Germany

5. Łukasiewicz Research Network–PORT Polish Center for Technology Development Wroclaw Poland

6. Cardiovascular Division Department of Medicine Washington University School of Medicine St. Louis MO

7. Department of Genetics Washington University School of Medicine St. Louis MO

8. McDonnell Genome Institute Washington University School of Medicine St. Louis MO

9. National Institute for Health and Welfare Helsinki Finland

10. Department of Mathematics and Statistics Faculty of Science University of Helsinki Finland

11. Department of Public Health Clinicum Faculty of Medicine University of Helsinki Finland

12. Center for Neurobehavioral Genetics Semel Institute for Neuroscience and Human Behavior University of California Los Angeles CA

13. Minerva Foundation Institute for Medical Research Biomedicum Helsinki Finland

14. Program in Medical and Population Genetics and The Stanley Center for Psychiatric Research The Broad Institute of MIT and Harvard Cambridge MA

15. Psychiatric and Neurodevelopmental Genetics Unit Department of Psychiatry, Analytic and Translational Genetics Unit Department of Medicine, and the Department of Neurology Massachusetts General Hospital Boston MA

16. Max Planck Institute of Cell Biology and Genetics Dresden Germany

Abstract

Background We asked whether, after excluding familial hypercholesterolemia, individuals with high low‐density lipoprotein cholesterol ( LDL ‐C) or triacylglyceride levels and a family history of the same hyperlipidemia have greater coronary artery disease risk or different lipidomic profiles compared with population‐based hyperlipidemias. Methods and Results We determined incident coronary artery disease risk for 755 members of 66 hyperlipidemic families (≥2 first‐degree relatives with similar hyperlipidemia) and 19 644 Finnish FINRISK population study participants. We quantified 151 circulating lipid species from 550 members of 73 hyperlipidemic families and 897 FINRISK participants using mass spectrometric shotgun lipidomics. Familial hypercholesterolemia was excluded using functional LDL receptor testing and genotyping. Hyperlipidemias ( LDL ‐C or triacylglycerides >90th population percentile) associated with increased coronary artery disease risk in meta‐analysis of the hyperlipidemic families and the population cohort (high LDL ‐C: hazard ratio, 1.74 [95% CI, 1.48–2.04]; high triacylglycerides: hazard ratio, 1.38 [95% CI, 1.09–1.74]). Risk estimates were similar in the family and population cohorts also after adjusting for lipid‐lowering medication. In lipidomic profiling, high LDL ‐C associated with 108 lipid species, and high triacylglycerides associated with 131 lipid species in either cohort (at 5% false discovery rate; P ‐value range 0.038–2.3×10 −56 ). Lipidomic profiles were highly similar for hyperlipidemic individuals in the families and the population ( LDL ‐C: r =0.80; triacylglycerides: r =0.96; no lipid species deviated between the cohorts). Conclusions Hyperlipidemias with family history conferred similar coronary artery disease risk as population‐based hyperlipidemias. We identified distinct lipidomic profiles associated with high LDL ‐C and triacylglycerides. Lipidomic profiles were similar between hyperlipidemias with family history and population‐ascertained hyperlipidemias, providing evidence of similar and overlapping underlying mechanisms.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3